Crescent Biopharma CBIO 深 沪
等待开盘 09-30 09:30:00 美东时间
14.76
+0.230
+1.58%
华盛通- 最 高15.62
- 今 开14.66
- 成交量 68.46万股
- 最 低 14.16
- 昨 收 14.53
- 总市值 54.82万
- 52周最高 27.41
- 市盈率 静 --
- 换手率 1843.16%
- 52周最低 8.72
- 委 比 -73.91%
- 总股本 3.71万
- 历史最高 3700.00
- 量 比 1.65
- 振 幅 10.05%
- 历史最低 8.72
- 每 手 1
- 风险率 3.61%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Sagimet Biosciences stock rises after pricing $115M securities offering
Sagimet Biosciences (SGMT) said it priced an underwritten offering of 8.75M Series A common shares at $10 per share, or pre-funded warrants to purchase 2.75M shares at $9.9999 per warrant for certain ...
今天 18:31
Celsius Stock’s (CELH) Next Catalyst Is Hiding on Store Shelves
Celsius Holdings ($CELH), the functional beverage maker, needs to prove that it...
今天 05:46
Iovance hits highest since 2024 as analysts cheer guidance raise
Iovance Biotherapeutics (IOVA) added more than 30% on Tuesday as analysts welcomed the cell therapy developer’s decision to raise its full-year revenue outlook to a level above the consensus, indicati...
今天 02:47
Lilly Advances Next-Gen Obesity Combo, Setting Up New Catalyst for LLY
Eli Lilly And Company ($LLY) announced an update on their ongoing clinical stud...
今天 00:30
Why AMD Is Spending $8.2 Billion On World Labs
Advanced Micro Devices Inc. (NASDAQ:AMD) is pursuing World Labs to gain deeper insight into next-generation AI workloads and strengthen the broader hardware-and-software ecosystem it needs to compete with NVIDIA Corp. (NASDAQ:NVDA) in artificial intelligence. World Labs Could Shape AMD’s Chip Roadma...
09-29 21:16
Iovance rises as 2026 revenue outlook tops analyst consensus
Iovance Biotherapeutics (IOVA) raised its full-year 2026 revenue guidance to $410M-$420M, up from the previous range of $350M-$370M. The new guidance is above the $402.8M analyst consensus. The compan...
09-29 19:44
Nike cut to Neutral by Piper Sandler; PT lowered to $38
Piper Sandler cut its price target on Nike (NKE) to $38 from $45 on expectations that a promotional backdrop and weaker athletic footwear demand will delay the sportswear maker’s recovery. Current PT ...
09-29 00:45
What's next for Intel after the SK Hynix partnership rumors?
Intel Corporation (INTC) surged over 12% following reports of a potential strategic partnership or joint venture with SK Hynix to support memory production at its Ohio manufacturing site. The potentia...
09-28 22:15
IonQ in focus as BofA starts with Buy rating
IonQ (IONQ) was in focus on Monday as Bank of America started coverage on the quantum computing firm with a Buy rating and a $60 price target. Shares fell 0.8% in premarket trading. "IonQ has used rec...
09-28 19:39
Crescent Biopharma Announces Grants of Inducement Awards
Crescent Biopharma granted stock options to two non-executive employees under its 2025 Inducement Plan, with a total of 31,200 shares. The options, approved on September 24, 2026, have a 10-year term and an exercise price of $14.24, vesting 25% after the first year and 1/48 monthly thereafter. The Company, focused on advancing cancer therapies, emphasizes leveraging multiple modalities for solid tumor treatments.
09-25 20:15
